High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix

Pathobiology

Volumn 66, Issue 5, 1998, Pages 240-246

  Radhakrishna Pillai, M ^a   Lakshmi, S ^a   Sreekala, S ^b   Ganga Devi, T ^a   Jayaprakash, P G ^a   Rajalakshmi, T N ^b   Chandrika Devi, C G ^b   Krishnan Nair, M ^a   Balaraman Nair, M ^c  

^a REGIONAL CANCER CENTRE   (India)

^b Department of Obstetrics   (India)

^c Department of Pathology   (India)

Author keywords

Cervix; E6; Histology; Human papillomavirus; Tumor progression

Indexed keywords

TRANSFORMING PROTEIN;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; UTERUS CARCINOMA; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0031668519     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028029     Document Type: Article

References (28)

1. Nandakumar A, Anantha N, Venugopal TC: Incidence, mortality and survival in cervical cancer in Bangalore, India. Br J Cancer 1995; 71:1348-1352.
2. Ponten J, Adami H-O, Bergstrom R, Dillner J, Friberg L-G, Guftafsson L, Miller AB, Parkin DM, Sparen P, Trichopoulos D: Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-25.
3. Hospital Cancer Registry: Annual Report. Regional Cancer Centre. Trivandrum, 1995.
4. Villa LL: Human papillomaviruses and cervical cancer. Adv Cancer Res 1997;71:321-341.
5. Madrigal M, Janicek MF, Sevin BU, Perras J, Estape R, Penalver M, Averette HE: In vitro antigene therapy targeting HPV - 16 E6 and E7 in cervical carcinoma. Gynecol Oncol 1997;64: 18-25.
6. Turek LP, Smith EM: The genetic program of genital human papillomaviruses in infection and cancer. Obstet Gynecol Clin North Am 1996;23:735-758.
7. Park JS, Hwang ES, Park SN, Ahn HK, Um SJ, Kim CJ, Kim SJ, Namkoong SE: Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol 1997;65:121-129.
8. Morrison EA: Natural history of cervical infection with human papillomaviruses. Clin Infect Dis 1994;18:172-180.
9. Bruan L, Durst M, Mikuma R, Crowley A, Robinson M: Regulation of growth and gene expression in human papillomavirus transformed keratinocytes by transforming growth factor β: Implications for the control of papillomaviruses. Mol Carcinog 1992;6:100-111.
10. Anwar K, Inuzuka M, Shiraishi T, Nakakuki K. Detection of HPV DNA in neoplastic and non neoplastic cervical specimens from Pakistan and Japan by non isotopic in situ hybridization. Im J Cancer 1991;47:675-680.
11. Higgs TW, Moore NJ, Badawi DY, Taub FE: Type specific human papillomavirus detection in formalin fixed paraffin embedded tissue sections using non radioactive deoxyribonucleic acid probes. Lab Invest 1990;63:557-567.
12. Ravi D, Nalinakumari KR, Rajaram RS, Nair MK, Pillai MR: Expression of programmed cell death regulatory p53 and bcl-2 proteins in oral lesions. Cancer Lett 1996;105:139-146.
13. Liang XH, Volkmann M, Klein R, Herman B, Locket SJ: Co-localization of the tumor suppressor protein p53 and human papillomavirus E6 protein in human cervical cell lines. Oncogene 1993;8:2645-2652.
14. Kaufman RH, Adam E, Kenogle J, Lawson H, Lee N, Reeves KO, Irwin J, Simon T, Press M, Uhler R, Entman C, Reeves WC: Relevance of human papillomavirus screening in the management of cervical intraepithelial neoplasia. Am J Obstet Gynecol 1997;176:87-92.
15. Zehbe I, Wilander E: Human papillomavirus infection and invasive cervical neoplasia: A study of prevalence and morphology J Pathol 1997;181:270-275.
16. Das BC, Sharma JK, Gobalakrishna V, Das DK, Singh V, Gissman L, zur Hausen H, Luthra UK: A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J Med Virol 1992;36:239-45.
17. Das BC, Gopalakrishna V, Sharma JK, Roy M, Luthra UK: Human papillomavirus DNA in urine of women with preneoplastic and neoplastic cervical lesions. Lancet 1992;340:1417-1418.
18. Das BC, Gopalakrishna V, Das DK, Sharma JK, Singh V, Luthra UK: Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women. Cancer 1993; 72:147-153.
19. Sarkar S, Verma K, Kaw H, Seth P: Detection of human papillomavirus types 16 and 18 DNA in cervical lesions of Indian women using in situ hybridization. Indian J Med Res 1992;96:356-360.
20. Kubbutat MHG, Vousden KH: Role of E6 and E7 oncoproteins in anogenital malignancies. Semin Virol 1996;7:295-304.
21. Scheffner M, Weraess BA, Huibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes degradation of p53. Cell 1990;63: 1129-1136.
22. Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, Laimins LA: Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53 mediated repression of transcription. EMBO J 1992;11:3045-3052.
23. Beer-Romero P, Glass S, Rolfe M: Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells. Oncogene 1997;14:595-602.
24. Pillai MR, Haiabi S, Mckalip A, Jayaprakash PG, Rajalekshmi TN Nair MK, Herman B: The presence of human papillomavinis-16/-18 E6, p53 and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 1996;5:329-335.
25. Monsonego J: Cellular and molecular pathogenesis of cervical carcinoma. Med Sci 1996; 12:733-744.
26. Matlashewski G: Human papillomaviruis update - 15th Annual International papulomavirus workshop. Int J Cancer 1997;71:715-718.
27. Henson DE: Future directions for the American Joint Committee on Cancer. Cancer 1992; 54:1639-1644.
28. Lakshmi S, Pillai MR, Nair SA, Jayaprakash PG, Nair MK: Cancer of the uterine cervix: Integration of molecular evaluation into management strategy and the concept of biological staging. Curr Sci 1995;68:45-52.